2021
DOI: 10.1016/j.tube.2021.102085
|View full text |Cite
|
Sign up to set email alerts
|

Improving host-directed therapy for tuberculous meningitis by linking clinical and multi-omics data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…As part of the ULTIMATE project 21 , we sequenced DNA from 239 tuberculous meningitis patients. The genomic DNA sample was fragmented randomly by Covaris technology, resulting in fragments of 350bp after selecting the appropriate size range.…”
Section: Star Methodsmentioning
confidence: 99%
“…As part of the ULTIMATE project 21 , we sequenced DNA from 239 tuberculous meningitis patients. The genomic DNA sample was fragmented randomly by Covaris technology, resulting in fragments of 350bp after selecting the appropriate size range.…”
Section: Star Methodsmentioning
confidence: 99%
“…Whether tryptophan metabolism plays such a critical role in SCTB is undetermined. [ 93 , 94 ] Finally, whether adjunctive agents such as tumor necrosis factor alpha-blockers such as infliximab and thalidomide and other immunomodulatory strategies can further improve outcomes of patients who worsen despite antimycobacterial therapy and steroids needs to be studied. The role of aspirin and antifibrinolytics in the management of TBRM also should be studied in randomized trials.…”
Section: T Reatment Of S Pinal ...mentioning
confidence: 99%
“…Host-directed therapies may act as adjunct treatment options for bacterial, viral, and parasitic infectious diseases. It includes commonly used drugs for communicable diseases with good safety profiles, immunomodulatory agents, biologics (e.g., monoclonal antibodies), nutritional products, and cellular therapy using the patient's own immune or bone marrow mesenchymal stromal cells [55] .…”
Section: Strategies To Deal With Challengementioning
confidence: 99%